Potential role of extracellular vesicle–mediated antigen presentation in Helicobacter pylori hypersensitivity during eradication therapy - 04/08/18

Takamasa Ito, MD ^a, Takashi Shiromizu, PhD ^c, Shunsuke Ohnishi, MD, PhD ^b, Shotaro Suzuki, PhD ^a, Katsuhiro Mabe, MD, PhD ^d, Akito Hasegawa, MD ^e, Hideyuki Ujiie, MD, PhD ^a, Yasuyuki Fujita, MD, PhD ^a, Yuichi Sato, MD, PhD ^f, Shuji Terai, MD, PhD ^f, Mototsugu Kato, MD, PhD ^d, Masahiro Asaka, MD, PhD ^g, Takeshi Tomonaga, MD, PhD ^c, Hiroshi Shimizu, MD, PhD ^a , Riichiro Abe, MD, PhD ^{a, e}

^a Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan 

^b Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan 

^c Laboratory of Proteome Research, National Institute of Biochemical Innovation, Health and Nutrition, Hyogo, Japan 

^d Department of Gastroenterology, National Hospital Organization Hakodate Hospital, Hakodate, Japan 

^e Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan 

^f Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan 

^g Health Sciences University of Hokkaido, Tobetsu, Japan